Characterizing clinician communication with patients about lecanemab: A qualitative study of clinicians across seven academic medical centers

Abstract INTRODUCTION Anti‐amyloid monoclonal antibodies (mAbs) slow cognitive decline in Alzheimer's disease but may cause amyloid‐related imaging abnormalities (ARIA), which can rarely be disabling or fatal. This qualitative study investigates how clinicians communicate the benefits and risks of m...

Täydet tiedot

Bibliografiset tiedot

Päätekijät:	Anna L. Parks, Ayush Thacker, Daniel Dohan, Liliana A. Ramirez Gomez, Seth A. Gale, Kim G. Johnson, Christine S. Ritchie, Sachin J. Shah, Joanna Paladino
Aineistotyyppi:	Artigo
Kieli:	Inglês
Julkaistu:	Wiley 2025-07-01
Sarja:	Alzheimer’s & Dementia: Translational Research & Clinical Interventions
Aiheet:	Alzheimer's disease anti‐amyloid monoclonal antibodies dementia care and practice mild cognitive impairment qualitative methods shared decision‐making
Linkit:	https://doi.org/10.1002/trc2.70150
Tagit:	Lisää tagi Ei tageja, Lisää ensimmäinen tagi!